EU Conference on Endocrine Disruptors: Current challenges in science and policy
Jun 11, 2012 08:00 AM
Jun 12, 2012 05:00 PM
|Brussels (BE), Charlemagne Building|
|Organizer: European Commission|
The presentations and discussions will cover the effects of endocrine disruptors on human health and the environment, the risks, the identification of endocrine disruptors and policy objectives
This conference, organized by the European Commission, aims to bring together all major stakeholders to discuss the challenges posed by endocrine disruptors. Speakers will include European Commissioners and international experts. The outcome of the conference will feed into the review of the European Commission's current strategy on endocrine disruptors. It will also provide input to the Commission's upcoming proposal for criteria for the identification of substances with endocrine disrupting properties. Such criteria are required under the Plant Protection Product Regulation and the Biocidal Products Regulation by the end of 2013. The Commission also has to review the way that endocrine disrupting substances are authorised under REACH by June 2013.
- New! Download final programme (updated 07.06.2012)
The conference aims to attract:
- Representatives (policy makers and scientific/risk assessment experts) of EU Member States
- Representatives of European Institutions
- Representatives (policy makers and scientific/risk assessment experts) of non-EU countries
- Representatives of international organisations
- Stakeholder representatives (NGOs and Industry)
- Academic scientists
The European Commission Joint Research Centre, Institute for Health and Consumer Protection (JRC-IHCP) will participate to the conference. JRC-IHCP activities on Endocrine Disruptors are summarized in this web section.
A recently published major study on 'State of the Art Assessment of Endocrine Disruptors' provides essential background material for the conference; download it from the EC Endocrine Disruptors web site:
- "State of the art assessment of endocrine disruptors"
- "Annex 1: Summary of the state of the science"
- "Annex 2: Summary of expert consultations on approaches to the regulatory assessment of endocrine disruptors"
- "Annex 3: Comparative analysis of endpoints and assays by human health and wildlife endpoint"
Photo: Scientists at work in the JRC, Institute for Health and Consumer Protection facilities. Copyright EU 2010.